Now showing items 11-20 of 83
Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action
(Cambridge University Press, 2013-11)
Non-competitive NMDA receptor antagonists are widely used as pharmacological models of schizophrenia due to their ability to evoke the symptoms of the illness. Likewise, serotonergic hallucinogens, acting on 5-HT2A receptors, ...
Atypical antipsychotics in the treatment of pathological aggression in children and adolescents: literature review and clinical recommendationsAntipsicóticos atípicos no tratamento da agressividade patológica em crianças e adolescentes: revisão da literatura e recomendações clínicas
(Associação de Psiquiatria do Rio Grande do Sul, 2013)